Recital 13, Regulation (EU) 2022/256

In forcesince 22 Feb 2022

To facilitate free movement, in particular of citizens who have been infected during the Omicron wave, Member States should be able to issue certificates of recovery retroactively, that is, based on rapid antigen tests carried out as from 1 October 2021, provided that the rapid antigen test concerned was included in the EU common list at the time the test result was produced. As of 1 October 2021, all rapid antigen tests included in the EU common list have been assessed against the further definitions, scope, considerations and criteria that had been agreed by the Health Security Committee on 21 September 2021. Moreover, such retroactive issuance also covers the period when the emergence of Omicron led to an increase in SARS-CoV-2 infections in the EU, resulting in a high testing demand and strained NAAT capacities. Retroactive issuance could take place on the basis of either data recorded in Member States’ healthcare records or a test certificate issued in the EU Digital COVID Certificate format.